A catalogue of somatic NRF2 gain-of-function mutations in cancer

Scientific Reports
Michael John Kerins, Aikseng Ooi

Abstract

Identification and characterization of somatic mutations in cancer have important prognostication and treatment implications. Genes encoding the Nuclear factor (erythroid-derived 2)-like 2 (NRF2) transcription factor and its negative regulator, Kelch-like ECH-associated protein 1 (KEAP1), are frequently mutated in cancer. These mutations drive constitutive NRF2 activation and correlate with poor prognosis. Despite its apparent significance, a comprehensive catalogue of somatic NRF2 mutations across different tumor types is still lacking. Here, we catalogue NRF2 mutations in The Cancer Genome Atlas (TCGA) database. 226 unique NRF2-mutant tumors were identified from 10,364 cases. NRF2 mutations were found in 21 out of the 33 tumor types. A total of 11 hotspots were identified. Of these, mutation to the R34 position was most frequent. Notably, R34 and D29 mutations were overrepresented in bladder, lung, and uterine cancers. Analyses of corresponding RNA sequencing data using a de novo derived gene expression classifier showed that the R34 mutations drive constitutive NRF2 activation with a selection pressure biased against the formation of R34L. Of all R34 mutants, R34L conferred the least degree of protein stabilization, suggesti...Continue Reading

References

Nov 14, 1997·The Journal of Biological Chemistry·T KamitaniE T Yeh
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Nov 3, 2004·Trends in Molecular Medicine·Hozumi Motohashi, Masayuki Yamamoto
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shin-ichi FukumotoHiroyuki Aburatani
Mar 2, 2006·Molecular Cell·Balasundaram PadmanabhanMasayuki Yamamoto
Oct 6, 2006·PLoS Medicine·Anju SinghShyam Biswal
Oct 13, 2006·Proceedings of the National Academy of Sciences of the United States of America·Zhaohui FengMoon-shong Tang
Aug 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jonathan M MaherCurtis D Klaassen
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Tatsuhiro ShibataSetsuo Hirohashi
Jan 17, 2009·Chemical Research in Toxicology·Hsiang-Tsui WangMoon-Shong Tang
Mar 27, 2009·Trends in Biochemical Sciences·John D Hayes, Michael McMahon
Sep 8, 2009·Toxicology and Applied Pharmacology·Mi-Kyoung Kwak, Thomas W Kensler
Dec 8, 2009·The Journal of Pathology·Yoo Ri KimSug Hyung Lee
Jun 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Luisa M SolisIgnacio I Wistuba
Sep 18, 2010·Chemico-biological Interactions·Albena T Dinkova-Kostova, Xiu Jun Wang
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael McMahonJohn D Hayes
Jan 21, 2011·Journal of Human Genetics·Qing Kay LiEdward Gabrielson
Mar 4, 2011·Archives of Toxicology·Stephen L Slocum, Thomas W Kensler
May 26, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Lucia Anna MuscarellaVito Michele Fazio
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Jun 17, 2011·Cancer Research·Panagiotis A KonstantinopoulosStephen A Cannistra
Oct 5, 2011·Neoplasia : an International Journal for Oncology Research·Tatsuhiro ShibataMasayuki Yamamoto
Dec 14, 2011·Journal of the National Cancer Institute·Vincent James CoglianoChristopher P Wild
Jul 20, 2012·Nature Reviews. Cancer·Michael B Sporn, Karen T Liby
Sep 12, 2012·Nucleic Acids Research·Yosuke HirotsuMasayuki Yamamoto
Oct 18, 2013·Respiratory Research·Page C SpiessAlbert van der Vliet
Oct 22, 2013·Genes & Development·Melba C Jaramillo, Donna D Zhang
Nov 2, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Xiu-Feng HuXiao-Shan Feng
Dec 25, 2013·Molecular and Cellular Biology·Toshiaki FukutomiMasayuki Yamamoto
Jul 24, 2014·Molecular Cancer Therapeutics·Naoki MineTakumi Kawabe
Oct 23, 2014·Journal of Cancer Prevention·Jae Hong NoYong Sang Song
Dec 18, 2014·Genome Biology·Michael I LoveSimon Anders
Apr 26, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Bhagavatula MoorthyDanielle J Carlin
Jun 29, 2015·Free Radical Biology & Medicine·Takafumi Suzuki, Masayuki Yamamoto

❮ Previous
Next ❯

Citations

Jan 25, 2019·Current Pharmaceutical Design·Gina MandaAntonio Cuadrado
Nov 14, 2019·PloS One·Gayle P PouliotAlejandro Gutierrez
Jan 11, 2019·Nucleic Acids Research·Daniel J Rigden, Xosé M Fernández
Oct 30, 2019·Pediatric Hematology and Oncology·Dilara Fatma Akın-BalıTeoman Kankılıc
Mar 5, 2020·Archives of Pharmacal Research·Eun-Ji Choi, Sang-Min Jeon
Mar 15, 2019·PloS One·Michael T BarrettAlan H Bryce
May 28, 2020·Cancers·Edyta ReszkaZbigniew Jabłonowski
May 30, 2020·Journal of Biomolecular Structure & Dynamics·Dilara Fatma Akın-BalıTugba Taskin-Tok
May 18, 2019·Oxidative Medicine and Cellular Longevity·Emiliano Panieri, Luciano Saso
Jan 6, 2019·Nature Reviews. Drug Discovery·Antonio CuadradoAlbena T Dinkova-Kostova
May 3, 2020·Cellular and Molecular Life Sciences : CMLS·Anuradha KirtoniaManoj Garg
Jan 29, 2020·Antioxidants & Redox Signaling·Katarína SmolkováPéter Bai
Aug 12, 2020·Nature Reviews. Cancer·Francisco Martínez-JiménezNuria Lopez-Bigas
Nov 19, 2020·Pigment Cell & Melanoma Research·José Pedro Friedmann Angeli, Svenja Meierjohann
Jun 24, 2020·Molecular Cancer Research : MCR·Yijun TianLiang Wang
Sep 16, 2020·Cancer Research·Suzy V Torti, Frank M Torti
Jan 7, 2021·Antioxidants & Redox Signaling·Emiliano Panieri, Luciano Saso
Aug 10, 2020·Free Radical Biology & Medicine·Thangarajeswari MohanKalaiselvi Periandavan
Jan 4, 2020·ACS Infectious Diseases·Megan R EdwardsChristopher F Basler
Nov 26, 2020·Cancers·Sara Clerici, Alessandra Boletta
Nov 26, 2020·Antioxidants·Sajan George, Heidi Abrahamse
Feb 26, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Samsul ArefinPeter Stenvinkel
Aug 13, 2020·Biomolecules & Therapeutics·Seung Eun LeeJongsung Lee
Feb 23, 2021·Cellular and Molecular Gastroenterology and Hepatology·Huabo WangEdward V Prochownik
Apr 26, 2021·The Journal of Biological Chemistry·Ferbian Milas SiswantoSusumu Imaoka
Jun 3, 2021·International Journal of Molecular Sciences·Hui XieRoman A Blaheta
Jun 3, 2021·International Journal of Molecular Sciences·Effi HaqueHiroaki Taniguchi
Jul 25, 2021·European Journal of Medicinal Chemistry·Vladimir SimovErin F DiMauro
Jul 28, 2021·Pharmacological Reviews·Trevor M PenningTea Lanišnik Rižner
Sep 17, 2021·Communications Biology·Elena V KnatkoAlbena T Dinkova-Kostova
Aug 19, 2021·American Journal of Physiology. Gastrointestinal and Liver Physiology·Yu TanakaAtsushi Masamune
Sep 10, 2021·Annual Review of Pharmacology and Toxicology·Laura Torrente, Gina M DeNicola

❮ Previous
Next ❯

Methods Mentioned

BETA
RNASeq
PCR
transfection

Software Mentioned

SomaticSniper
house
VarScan2
DESeq
MuSE
MuTect2
Rcpp package
R
TCGA
ImageJ

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.